Advertisement
Screener

DarioHealth Corp. (DRIO) Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture

1.9 / 5 stars · 38/98 Roast Me

DarioHealth Corp. Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • DarioHealth Corp. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2021-12-31 was $19.00K.
  • DarioHealth Corp. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2021-09-30 was $34.00K, a 82.38% decline year-over-year.
  • DarioHealth Corp. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2021-06-30 was $27.00K, a 80.85% decline year-over-year.
  • DarioHealth Corp. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2021-03-31 was $72.00K, a 73.72% decline year-over-year.
  • DarioHealth Corp. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2021 was $152.00K, a 84.85% decline from fiscal 2020.
  • DarioHealth Corp. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2020 was $1.00M, a 0.79% decline from fiscal 2019.
  • DarioHealth Corp. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2019 was $1.01M, a 4.17% decline from fiscal 2018.
  • DarioHealth Corp. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2018 was $1.05M, a 49.22% increase from fiscal 2017.
Period endShares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 monthShares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month
2021-12-31$19.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09
$152.00K
10-K · filed 2023-03-09
2021-09-30$34.00K
10-Q · filed 2022-11-14
2021-06-30$27.00K
10-Q · filed 2022-08-15
2021-03-31$72.00K
10-Q · filed 2022-08-15
2020-12-31$1.00M
10-K · filed 2022-03-22
2020-09-30$193.00K
10-Q · filed 2021-11-15
2020-06-30$141.00K
10-Q · filed 2021-11-15
2020-03-31$274.00K
10-Q · filed 2021-11-15
2019-12-31$1.01M
10-K · filed 2021-03-09
2019-09-30$445.00K
10-Q · filed 2020-11-12
$1.04M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$141.00K
10-Q · filed 2020-11-12
$809.00K
derived: sum of 4 quarters · filed 2020-11-12
2019-03-31$210.00K
10-Q · filed 2020-11-12
$1.10M
derived: sum of 4 quarters · filed 2020-11-12
2018-12-31$246.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17
$1.05M
10-K · filed 2020-03-17
2018-09-30$212.00K
10-Q · filed 2019-10-28
$969.00K
derived: sum of 4 quarters · filed 2019-10-28
2018-06-30$436.00K
10-Q · filed 2019-10-28
$923.00K
derived: sum of 4 quarters · filed 2019-10-28
2018-03-31$161.00K
10-Q · filed 2019-10-28
$618.00K
derived: sum of 4 quarters · filed 2019-10-28
2017-12-31$160.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25
$707.00K
10-K · filed 2019-03-25
2017-09-30$166.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-19
$547.00K
derived: sum of 4 quarters · filed 2018-03-19
2017-06-30$131.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-03-19
$498.00K
derived: sum of 4 quarters · filed 2018-03-19
2017-03-31$250.00K
10-Q · filed 2018-03-19
$485.00K
derived: sum of 4 quarters · filed 2018-03-19
2016-12-31$0.00
derived: 10-Q 12 month − 10-Q 9 month · filed 2018-03-19
$310.00K
10-Q · filed 2018-03-19
2016-09-30$117.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
$382.00K
derived: sum of 4 quarters · filed 2017-03-22
2016-06-30$118.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11
2016-03-31$75.00K
10-Q · filed 2016-05-11
2015-12-31$72.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22
$304.00K
10-K · filed 2017-03-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
CVRx, Inc. (CVRX)United States$0.067B-2.62
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
TELA Bio, Inc. (TELA)United States$0.057B-0.82
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Spectral AI, Inc. (MDAI)United States$0.052B
Pulmonx Corp (LUNG)United States$0.082B-1.16
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17
LENSAR, Inc. (LNSR)United States$0.087B2.02